MNOV
MEDICINOVA INC
NASDAQ · Healthcare · Biotechnology · US
$3.32
−3.77%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- $50.0K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.06
- Revenue actual
- $459.0K
- Revenue estimate
- $75.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +22.8%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.06 | -$0.05 | Beat 21.05% | $459.0K |
| May 15, 2026 | -$0.06 | -$0.05 | Beat 16.67% | $187.0K |
| Feb 20, 2026 | -$0.07 | -$0.05 | Beat 28.57% | $151.7K |
| Nov 12, 2025 | -$0.08 | -$0.06 | Beat 25.00% | $123.3K |
| Aug 14, 2025 | -$0.07 | -$0.07 | In line | $134.6K |
| Feb 19, 2025 | -$0.06 | -$0.06 | In line | — |
| Nov 13, 2024 | -$0.06 | -$0.06 | In line | — |
| Aug 8, 2024 | -$0.06 | -$0.05 | Beat 16.67% | — |
| May 9, 2024 | -$0.05 | -$0.06 | Miss -20.00% | — |
| Feb 15, 2024 | -$0.08 | -$0.04 | Beat 50.00% | -$999.8M |
| Nov 9, 2023 | -$0.08 | -$0.01 | Beat 87.50% | $1.0B |
| May 11, 2023 | -$0.07 | -$0.06 | Beat 14.29% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026